Back
Endava plc - ADR Vs. Akero Therapeutics Industry Stock Comparison
Sell
13
DAVA
Endava plc - ADR
Last Price:
$12.81
Seasonality Move:
6.66%
Sell
37
AKRO
Akero Therapeutics
Last Price:
$48.60
Seasonality Move:
26.87%
Sell
13
Endava plc - ADR (DAVA)
is a Sell
Is Endava plc - ADR a Buy, Sell or Hold?
-
The current Endava plc - ADR [DAVA] share price is $12.59. The Score for DAVA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $49.38. The Score for AKRO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAVA Stock Price Chart
What is Endava plc - ADR's stock price today?
-
The Endava plc - ADR share price today is $12.59The current trend is moderately bullish and DAVA is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $49.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.15 | Buy |
Relative Strength Index (14 RSI): | 43.26 | Sell |
Chaikin Money Flow: | -1003717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.32 - 14.26) | Sell |
Bollinger Bands (100): | (13.57 - 18.39) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 47.31 | Sell |
Chaikin Money Flow: | 1491006 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.44 - 52.22) | Sell |
Bollinger Bands (100): | (40.88 - 53.18) | Buy |
DAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.67 | Sell |
20-day SMA: | 13.24 | Sell |
50-day SMA: | 14.27 | Sell |
200-day SMA: | 22.17 | Sell |
8-day EMA: | 12.44 | Buy |
20-day EMA: | 9.58 | Buy |
50-day EMA: | 5.44 | Buy |
200-day EMA: | 1.66 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.72 | Sell |
20-day SMA: | 49.69 | Sell |
50-day SMA: | 51.97 | Sell |
200-day SMA: | 41.9 | Buy |
8-day EMA: | 49.36 | Buy |
20-day EMA: | 49.88 | Sell |
50-day EMA: | 49.93 | Sell |
200-day EMA: | 43.03 | Buy |
Endava plc - ADR Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.
Endava plc - ADR Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |